Trial watch – inhibiting PARP enzymes for anticancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trial watch – inhibiting PARP enzymes for anticancer therapy

Published:2015-06-10 Issue:2 Volume:3 Page:e1053594
ISSN:2372-3556
Container-title:Molecular & Cellular Oncology
language:en
Short-container-title:Molecular & Cellular Oncology

Author:

Sistigu Antonella¹,Manic Gwenola¹,Obrist Florine²³⁴⁵,Vitale Ilio¹⁶

Affiliation:

1. Regina Elena National Cancer Institute, Rome, Italy

2. Université Paris-Sud/Paris XI, Le Kremlin-Bicêtre, France

3. INSERM, UMRS1138, Paris, France

4. Equipe 11 labelisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France

5. Gustave Roussy Cancer Campus, Villejuif, France

6. Department of Biology, University of Rome “TorVergata”, Rome, Italy

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23723556.2015.1053594

Reference330 articles.

1. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

2. Poly(ADP-ribose): novel functions for an old molecule

3. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions

4. (ADP-ribose)n participates in DNA excision repair

5. Poly(ADP-ribose). The most elaborate metabolite of NAD+

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects;Cancer Research Communications;2022-11-15

2. Three dimensional and microphysiological bone marrow models detect in vivo positive compounds;Scientific Reports;2021-11-09

3. Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report;BMC Cancer;2020-01-20

4. Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy;Cancers;2019-03-05

5. Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity;Microbiology and Molecular Biology Reviews;2019-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3